Dr Reddys Laboratories (RDY) Tax Provisions (2009 - 2023)

Dr Reddys Laboratories' Tax Provisions history runs 14 years deep, the most recent figure standing at $60.0 million for Q2 2023.

• On a quarterly basis, Tax Provisions changed N/A year-over-year to $60.0 million in Q2 2023; TTM through Jun 2023 was $195.0 million, a N/A change from a year earlier, with the FY2026 full-year figure at $132.0 million, down 42.36% from the prior year.
• Tax Provisions climbed to $60.0 million in Q2 2023 per RDY's latest filing, from $53.0 million in the prior quarter.
• Across five years, Tax Provisions topped out at $60.0 million in Q2 2023 and bottomed at -$46.0 million in Q2 2019.
• The 4-year median for Tax Provisions is $37.0 million (2021), against an average of $26.4 million.
• Biggest YoY gain for Tax Provisions was 428.57% in 2019; the steepest drop was 428.57% in 2019.
• Year by year, Tax Provisions stood at $13.0 million in 2019, then surged by 184.62% to $37.0 million in 2021, then advanced by 21.62% to $45.0 million in 2022, then surged by 33.33% to $60.0 million in 2023.
• Per Business Quant, the three latest RDY Tax Provisions figures stand at $60.0 million (Q2 2023), $53.0 million (Q1 2023), and $45.0 million (Q4 2022).